ChartRow logo
PFE
Pfizer Inc.Stock · Healthcare · S&P 500 0.3%
$27.25+$0.38 (+1.41%)as of market close, Aug 18, 2026
☀ Pre-market:$27.29+0.15%6:54 AM ET
CompareLLYUNHJNJISRGABBVTMO

PFE financial statements

The full income statement, balance sheet, and cash-flow statement for Pfizer Inc. (PFE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 5.67B2024-09 5.67B2024-12 5.67B2025-03 5.69B2025-06 5.69B2025-09 5.69B2025-12 5.69B2026-03 5.70B2026-06 5.70B+0.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

About this data

Source: PFE's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PFE filings on SEC EDGAR → Not investment advice.